Unknown PHASE3 INTERVENTIONAL 2-arm NCT01226303

Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia

Sponsor: Associazione Italiana Ematologia Oncologia Pediatrica

Updated 6 times since 2017 Last updated: Jan 25, 2017 Started: Jan 31, 2009 Primary completion: Jun 30, 2017 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01226303, this PHASE3 trial focuses on Acute Promyelocytic Leukemia and remains ongoing. Sponsored by Associazione Italiana Ematologia Oncologia Pediatrica, it has been updated 6 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2019 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jun 2018 — Jan 2019 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Associazione Italiana Ematologia Oncologia Pediatrica

Data source: Associazione Italiana Ematologia Oncologia Pediatrica

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Roma, Italy